| Comprehensive evaluation of programmed death-ligand 1 expression in primary and metastatic prostate cancer MC Haffner, G Guner, D Taheri, GJ Netto, DN Palsgrove, Q Zheng, ... The American journal of pathology 188 (6), 1478-1485, 2018 | 146 | 2018 |
| Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax K Kim, A Maiti, S Loghavi, R Pourebrahim, TM Kadia, CR Rausch, ... Cancer 127 (20), 3772-3781, 2021 | 98 | 2021 |
| Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen SC Cha, H Qin, S Kannan, S Rawal, LS Watkins, FE Baio, W Wu, J Ong, ... The Journal of Immunology 190 (9), 4887-4898, 2013 | 56 | 2013 |
| Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome KS Chien, K Kim, GM Nogueras‐Gonzalez, G Borthakur, K Naqvi, ... British journal of haematology 195 (3), 378-387, 2021 | 40 | 2021 |
| Venetoclax resistance: mechanistic insights and future strategies F Ong, K Kim, MY Konopleva Cancer Drug Resistance 5 (2), 380, 2022 | 36 | 2022 |
| AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination MC Haffner, DM Esopi, A Chaux, M Gürel, S Ghosh, AM Vaghasia, H Tsai, ... Nature communications 8 (1), 142, 2017 | 35 | 2017 |
| Novel BAFF-receptor antibody to natively folded recombinant protein eliminates drug-resistant human B-cell malignancies in vivo H Qin, G Wei, I Sakamaki, Z Dong, WA Cheng, DL Smith, F Wen, H Sun, ... Clinical Cancer Research 24 (5), 1114-1123, 2018 | 28 | 2018 |
| Understanding hearing loss and barriers to hearing health care among Korean American older adults: A focus group study JS Choi, KS Shim, K Kim, CL Nieman, SK Mamo, FR Lin, HR Han Journal of Applied Gerontology 37 (11), 1344-1367, 2018 | 24 | 2018 |
| Outcomes of TP53-mutant acute myeloid leukemia with venetoclax and decitabine K Kim, A Maiti, TM Kadia, F Ravandi, N Daver, N Pemmaraju, G Borthakur, ... Blood 136, 33-36, 2020 | 16 | 2020 |
| Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: Study protocol SK Thomas, S Cha, DL Smith, KH Kim, SR Parshottam, S Rao, ... BMC cancer 18, 1-9, 2018 | 16 | 2018 |
| A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma MH Qazilbash, NY Saini, S Cha, Z Wang, EA Stadtmauer, ... Blood, The Journal of the American Society of Hematology 139 (9), 1289-1301, 2022 | 10 | 2022 |
| Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes D Rivera, K Kim, R Kanagal‐Shamanna, G Borthakur, ... American journal of hematology 97 (12), 1599-1606, 2022 | 9 | 2022 |
| Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant K Kim, E Jabbour, NJ Short, P Kebriaei, H Kantarjian, F Ravandi Current oncology reports 23 (8), 95, 2021 | 9 | 2021 |
| The use of direct acting oral anticoagulants in patients with COVID-19 infection R Aly, S Gupta, B Singh, P Kaur, K Kim, S Gupta Journal of community hospital internal medicine perspectives 11 (2), 184-186, 2021 | 9 | 2021 |
| Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study K Kim, TH Chung, CJ Etzel, J Kim, H Ryu, DW Kim, P Hwu, WJ Hwu, ... Cancer Epidemiology 57, 80-84, 2018 | 8 | 2018 |
| Current Understanding of DDX41 Mutations in Myeloid Neoplasms K Kim, F Ong, K Sasaki Cancers 15 (2), 344, 2023 | 7 | 2023 |
| A phase II study of CPX-351 plus venetoclax in patients with relapsed/refractory (R/R) or newly diagnosed acute myeloid leukemia (AML) K Kim, H Kantarjian, G Borthakur, K Takahashi, NJ Short, CD DiNardo, ... Blood 138, 1275, 2021 | 7 | 2021 |
| Randomized phase II trial of combination idiotype vaccine and anti-CD3/anti-CD28 costimulated autologous T cells in patients with multiple myeloma post-autotransplantation MH Qazilbash, EA Stadtmauer, V Baladandayuthapani, H Lin, BM Tross, ... Blood, The Journal of the American Society of Hematology 128 (22), 4548-4548, 2016 | 7 | 2016 |
| Clinical characteristics of patients with non-V600 BRAF mutant melanomas. DW Kim, S Nowroozi, K Kim, MA Davies, M Routbort, AJF Lazar, ... Journal of Clinical Oncology 32 (15_suppl), 9100-9100, 2014 | 6 | 2014 |
| Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials K Kim, M Konopleva, CD DiNardo, G Borthakur, S Loghavi, G Tang, ... American journal of hematology 97 (7), 885-894, 2022 | 5 | 2022 |
